These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12140005

  • 21. Mechanism of action of botulinum neurotoxin: Unexpected consequences.
    Hallett M.
    Toxicon; 2018 Jun 01; 147():73-76. PubMed ID: 28803760
    [Abstract] [Full Text] [Related]

  • 22. Clinical differences between botulinum neurotoxin type A and B.
    Bentivoglio AR, Del Grande A, Petracca M, Ialongo T, Ricciardi L.
    Toxicon; 2015 Dec 01; 107(Pt A):77-84. PubMed ID: 26260691
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
    Mazzocchio R, Caleo M.
    Neuroscientist; 2015 Feb 01; 21(1):44-61. PubMed ID: 24576870
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of MR-Tractography Findings in Hemifacial Spasm Patients Injected with Botulinum Neurotoxin.
    Cavus H, İşeri P, Öztürk O, Anık Y.
    Neurol India; 2022 Feb 01; 70(2):543-547. PubMed ID: 35532617
    [Abstract] [Full Text] [Related]

  • 32. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K.
    Toxins (Basel); 2019 Jan 17; 11(1):. PubMed ID: 30658420
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A.
    BioDrugs; 2010 Jun 17; 24(3):173-82. PubMed ID: 20462283
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products.
    Kutschenko A, Bigalke H, Wegner F, Wohlfarth K.
    Toxicon; 2019 Oct 17; 168():158-163. PubMed ID: 31323228
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Mechanism of therapy effects by botulinum neurotoxin].
    Alajbegović A, Alajbegović S, Resić H.
    Med Arh; 2008 Oct 17; 62(1):53-5. PubMed ID: 18543757
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.